GlobeStar Therapeutics Corp GSTC

$0.00 0.00 (0.00%)
View Full Chart
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover GSTC, but with our powerful screener, you can find stocks in the same sector, industry, or style and filter on our unbiased ratings and valuation metrics.

Trading Information

Previous Close Price
$0.00
Day Range
$0.00–0.00
52-Week Range
$0.00–0.00
Bid/Ask
$0.00 / $0.00
Shares Outstanding
1.24B
Market Cap
$1,241.11
Volume/Avg
15,000 / 818,877

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
—
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

GlobeStar Therapeutics Corp is a clinical-stage pharmaceutical company introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is focused on developing therapies for people with serious and life-threatening rare disorders.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
—
Total Number of Employees
0

Valuation

Metric
GSTC
Price/Earnings (Normalized)
—
Price/Book Value
—
Price/Sales
—
Price/Cash Flow
—
Price/Earnings
GSTC

Financial Strength

Metric
GSTC
Quick Ratio
0.00
Current Ratio
0.05
Interest Coverage
−9.77
Quick Ratio
GSTC

Profitability

Metric
GSTC
Return on Assets (Normalized)
−1,604.58%
Return on Equity (Normalized)
—
Return on Invested Capital (Normalized)
—
Return on Assets
GSTC

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
LOCK|n&!L$^LOCK|Z&?!#$127B
Moderna Inc
MRNA
LOCK|pCq#gS@LOCK|&D$87B
Regeneron Pharmaceuticals Inc
REGN
LOCK|sl>?scLOCK|@Nt@$81B
argenx SE ADR
ARGX
LOCK|HWpqLshLOCK|RNj$51B
BeOne Medicines Ltd ADR
ONC
LOCK|tsL?nnHLOCK|?!#$44B
Alnylam Pharmaceuticals Inc
ALNY
LOCK|#vk!pwLOCK|p?$R$31B
Royalty Pharma PLC Class A
RPRX
LOCK|&YRdx?@LOCK|xJ#k$27B
Incyte Corp
INCY
LOCK|$$rp$#?LOCK|^&$23B
BioNTech SE ADR
BNTX
LOCK|?%Zt$JLOCK|b<$22B
Jazz Pharmaceuticals PLC
JAZZ
LOCK|&yw?X<gLOCK|<<N$14B

Sponsor Center